Cheng Yu-Wei

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD”.

The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD

Nature Communications(2024)10.1038/s41467-024-50500-z

N/A

0.692DataRank · unranked

31 citations

Ruchi Sharma, Sridhar Bammidi, Victoria Koontz, Mihir Nemani, Meysam Yazdankhah +29 more

The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in atrophic AMD

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.08.552343

N/A

0DataRank · unranked

3 citations

Ruchi Sharma, Sridhar Bammidi, Victoria Koontz, Mihir Nemani, Meysam Yazdankhah +21 more